Guardant Health, Inc.
Guardant Health, Inc. (GH) — Form 8-K: Current report
AI-generated summary
Guardant Health, Inc. announced that its Board of Directors approved performance-based restricted stock unit awards for its co-founders and Co-Chief Executive Officers, Helmy Eltoukhy and AmirAli Talasaz. Each Co-CEO received a target grant of 465,413 PSUs. The awards vest based on total shareholder return relative to the S&P 500 Index over three-year and five-year performance periods.
Key facts
- Item 5.02 · Executive or director change or pay arrangement
- Item 9.01 · Financial statements and exhibits
More GH filings
- 4
Filed Oct 22, 2026
- 4
Filed Oct 19, 2026
- 4
Filed Oct 19, 2026
- 144
Filed Oct 16, 2026
- 4
Filed Oct 15, 2026
- 144
Filed Oct 14, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.